SomaLogic's Corporate Minority - III Round

SomaLogic raised a round of funding on October 21, 2014. Investors include Novartis.

SomaLogic is a protein biomarker discovery and clinical diagnostics company leveraging its Slow Off-rate Modified Aptamer (SOMAmer) technology. The company aims to develop and commercialize breakthrou…

Articles about SomaLogic's Corporate Minority - III Round: